Humanigen Announces Completion of Benznidazole Bioavailability Study
08 août 2017 08h00 HE
|
Humanigen, Inc.
BRISBANE, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today...
KaloBios Receives $5.0M in New Funding Commitment From Existing Investors
12 juil. 2017 16h10 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., July 12, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios CEO to Present at Two Upcoming Investor Conferences
31 mai 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...